| AAPAs | Anti-acetylated protein antibodies |
| Ab | Antibody |
| ACPAs | Anti-citrullinated protein/peptide antibodies |
| ACR | American College of Rheumatology |
| Ab | Antibody |
| Ag | Antigen |
| AMPAs | Anti-modified protein antibodies |
| Anti-CarP | Anti-carbamylated protein |
| Anti-MCV | Anti-mutated citrullinated vimentin antibodies |
| APC | Antigen presenting cell |
| Apo E | Apolipoprotein E |
| AutoAb | Autoantibody |
| AutoAg | Autoantigen |
| BIP | Immunoglobulin binding protein |
| BMI | Body mass index |
| CD | Cluster of differentiation |
| CD4+ T cell | Cluster of differentiation 4 positive T cell |
| CD40L | Cluster of differentiation 4 ligand |
| CEP-1 | Citrullinated enolase peptide-1 |
| c-LDL | Carbamylated LDL |
| CNS | Central nervous system |
| COPD | Chronic obstructive pulmonary disease |
| CRP | C-reactive protein |
| CTLA-4 | Cytotoxic T lymphocyte antigen 4 |
| DKK-1 | Dickkopf-1 |
| DMARDs | Disease-modifying antirheumatic drugs |
| EBV | Epstein–Barr virus |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| EPO | Erythropoietin |
| ER | Endoplasmic reticulum |
| ERK | Extracellular signal-regulated kinase |
| ESR | Erythrocyte sedimentation rate |
| ESRD | End stage renal disease |
| EULAR | European League Against Rheumatism |
| Fc | Constant fragment |
| FLNA | Filamin A |
| FLS | Fibroblast-like synoviocyte |
| FOXP3 | Forkhead box P3 |
| FUSE-BP | Far upstream element-binding proteins |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| GNS | N-acetylglucosamine-6-sulfatase |
| GWAS | Genome-wide association studies |
| HIP-1 | Huntingtin-interacting protein-1 |
| HLA | Human leukocyte antigen |
| IBD | Inflammatory bowel disease |
| IC | Immune complex |
| IFN-γ | Interferon-γ |
| Ig | Immunoglobulin |
| IKK | Inhibitor of NF-κB kinase |
| IL | Interleukin |
| IP | Interphalangeal joint |
| IRAK1 | Interleukin-1 receptor-associated kinase 1 |
| ITP | Immune thrombocytopenia |
| IV | Intravenous |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| LDL | Low-density lipoprotein |
| LTH | Leukotoxic hypercitrullination |
| LtxA | Leukotoxin A |
| MAC | Membrane attack complex |
| MAPKs | Mitogen-activated protein kinases |
| MCP | Metacarpophalangeal joint |
| MHC | Major histocompatibility complex |
| MMP | Matrix metalloproteinase |
| MNDA | Myeloid nuclear differentiation antigen |
| MPO | Myeloperoxidase |
| MS | Multiple sclerosis |
| MTP | Metatarsophalangeal joint |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NET | Neutrophil extracellular trap |
| NF | Nuclear factor |
| NTZ | Nitazoxanide |
| OA | Osteoarthritis |
| OB | Osteoblast |
| OC | Osteoclast |
| PAD | Peptidylarginine deiminase |
| pI | Iso-electric point |
| PIP | Proximal interphalangeal joint |
| PM | Particulate matter |
| PNS | Peripheral nervous system |
| PO | per os (orally) |
| PPAD | PAD of Porphyromonas gingivalis |
| PTM | Posttranslational modification |
| PTPN22 | Protein tyrosine phosphatase N22 |
| PVL | Panton–Valentine leukocidin |
| RA | Rheumatoid arthritis |
| RA-SF | Synovial fluid of rheumatoid arthritis patients |
| RF | Rheumatoid factor |
| SC | Subcutaneous |
| SE | Shared epitope |
| SF | Synovial fluid |
| SLE | Systemic lupus erythematosus |
| SLO | Streptolysin O |
| SNP | Single-nucleotide polymorphism |
| STAT | Signal transducers and activators of transcription |
| STEMI | ST-segment elevation myocardial infarction |
| Syk | Spleen tyrosine kinase |
| TCR | T cell receptor |
| Teff cell | Effector T cells |
| TGF-β | Transforming growth factor-β |
| TH1 cell | Helper T1 cell |
| TH17 cell | Helper T17 cell |
| TLR | Toll-like receptor |
| TNF | Tumor necrosis factor |
| TRAF1-C5 | TNF receptor associated factor 1-C5 |
| TReg cell | Regulatory T cell |
| Tyk | Tyrosine kinase |
| ULN | Upper limit of normal |
| FDA | US Food and Drug Administration |